natgillin/translations-raw huggingface dataset:
The eHealth Network shall pursue the objectives assigned to it by Article 14(2) of Directive 2011/24/EU.
Mreža e-zdravja izpolnjuje cilje, ki jih ji določa člen 14(2) Direktive 2011/24/EU.
In pursuing those objectives the eHealth Network shall work in close cooperation with the Joint Action and the Thematic Network and shall build on the results achieved in the framework of those two activities.
Pri izpolnjevanju navedenih ciljev mreža e-zdravja tesno sodeluje s skupnim ukrepom in tematsko mrežo ter gradi na dosežkih pri teh dveh dejavnostih.
Members shall be Member States’ authorities responsible for eHealth designated by those Member States participating in the eHealth Network.
Člani so organi držav članic, ki so pristojni za e-zdravje in jih imenujejo države članice, ki sodelujejo pri mreži e-zdravja.
Member States wishing to participate in the eHealth Network shall notify in writing to the Commission this intention as well as the national authority responsible for eHealth they have designated in accordance with Article 14(1) of Directive 2011/24/EU.
Države članice, ki želijo sodelovati pri mreži e-zdravja, o svoji nameri pisno obvestijo Komisijo in nacionalni organ, ki je pristojen za e-zdravje in ki so ga imenovale v skladu s členom 14(1) Direktive 2011/24/EU.
Each national authority responsible for eHealth shall nominate one representative in the eHealth Network, as well as one alternate, and shall communicate this information to the Commission.
Vsak nacionalni organ, pristojen za e-zdravje, imenuje v mreži e-zdravja po enega predstavnika in enega namestnika ter o tem obvesti Komisijo.
The names of Member States’ authorities may be published in the Register of Commission expert groups and other similar entities (‘the Register’).
Imena organov držav članic so objavljena v registru strokovnih skupin Komisije in drugih podobnih subjektov (v nadaljnjem besedilu: register).
Personal data of representatives of Member States, experts and observers participating in the Network shall be collected, processed and published in accordance with Directives 95/46/EC and 2002/58/EC.
Osebni podatki predstavnikov držav članic, strokovnjakov in opazovalcev, ki sodelujejo v mreži e-zdravja, se zbirajo, obdelujejo in objavijo v skladu z direktivama 95/46/ES in 2002/58/ES.
Relation between the eHealth Network and the Commission
Odnos med mrežo e-zdravja in Komisijo
The Commission may consult the eHealth Network on any matter relating to eHealth in the Union, in particular when this is needed in order to provide guidance to the Joint Action and the Thematic Network.
Komisija se lahko posvetuje z mrežo e-zdravja o kateri koli zadevi v zvezi z e-zdravjem v Uniji, zlasti kadar je to potrebno zaradi usmerjanja skupnega ukrepa in tematske mreže.
Any Member of the eHealth Network may advise the Commission to consult the eHealth Network on a specific question.
Kateri koli član mreže e-zdravja lahko svetuje Komisiji, naj se posvetuje z mrežo e-zdravja o posebnem vprašanju.
The eHealth Network shall adopt by a simple majority of its Members its own rules of procedure on the proposal by the Commission services, following consultation with the Member States participating in the Network.
Mreža e-zdravja z navadno večino svojih članov sprejme poslovnik na predlog služb Komisije po posvetovanju z državami članicami, ki sodelujejo v mreži.
The eHealth Network may set up sub-groups to examine specific questions on the basis of terms of reference defined by it.
Mreža e-zdravja lahko ustanovi podskupine za preučitev posebnih vprašanj pod referenčnimi pogoji, ki jim jih sama določi.
Such sub-groups shall be disbanded as soon as their mandate is fulfilled.
Take podskupine se razpustijo takoj, ko izpolnijo nalogo.
The eHealth Network shall adopt a multiannual work programme and an evaluation instrument on the implementation of such programme.
Mreža e-zdravja sprejme večletni delovni program in instrument za oceno njegovega izvajanja.
Members of the eHealth Network and their representatives, as well as invited experts and observers, shall comply with the obligations of professional secrecy laid down by Article 339 of the Treaty and its implementing rules, as well as with the Commission’s rules on security regarding the protection of EU classified information, laid down in the Annex to Commission Decision 2001/844/EC, ECSC, Euratom of 29 November 2001 amending its internal Rules of Procedure [7].
Člani mreže e-zdravja in njihovi predstavniki ter povabljeni strokovnjaki in opazovalci spoštujejo obveznosti o varovanju poslovnih skrivnosti iz člena 339 Pogodbe in njenih izvedbenih pravilih ter iz Pravilnika Komisije o varnosti v zvezi z zaščito tajnih podatkov EU iz Priloge k Sklepu Komisije 2001/844/ES, ESPJ, Euratom z dne 29. novembra 2001 o spremembah njenega poslovnika [7].
Should they fail to respect these obligations, the Chair of the eHealth Network may take all appropriate measures.
Če teh obveznosti ne spoštujejo, lahko predsedujoči mreže e-zdravja ukrene vse potrebno.
Secretariat of the eHealth Network
Sekretariat mreže e-zdravja
The Commission shall provide secretarial services for the eHealth Network.
Komisija zagotovi tajniško podporo mreži e-zdravja.
Other Commission officials with an interest in the proceedings may attend meetings of the eHealth Network and its sub-groups.
Sestankov mreže e-zdravja in njenih podskupin se lahko udeležujejo tudi drugi uradniki Komisije, ki jih zanimajo razprave.
The Commission shall publish relevant information on the activities carried out by the eHealth Network either by including it in the Register or via a link from the Register to a dedicated website.
Komisija objavi ustrezne informacije o dejavnostih mreže e-zdravja v samem registru ali s povezavo z registra na posebno spletno stran.
Participants in the activities of the eHealth Network shall not be remunerated by the Commission for their services.
Komisija ne plača sodelujočih za delo pri dejavnostih mreže e-zdravja.
Travel and subsistence expenses incurred by participants in the activities of the eHealth Network shall be reimbursed by the Commission in accordance with the provisions in force within the Commission.
Komisija sodelujočim povrne potne stroške in stroške bivanja v zvezi z dejavnostmi mreže e-zdravja v skladu z veljavnimi predpisi Komisije.
Those expenses shall be reimbursed within the limits of the available appropriations allocated under the annual procedure for the allocation of resources.
Navedeni stroški se povrnejo v mejah razpoložljivih odobrenih sredstev, dodeljenih po letnem postopku razporeditve sredstev.
Done in Brussels, 22 December 2011.
V Bruslju, 22. decembra 2011
OJ L 88, 4.4.2011, p. 45.
UL L 88, 4.4.2011, str. 45.
Joint Action on eHealth Governance Initiative; Commission Decision C(2010) 7593 of 27 October 2010 on the awarding of grants for proposals for 2010 under the second Health Programme (2008-2013), Contract number 2010/2302.
Skupni ukrep za pobudo za upravljanje e-zdravja; Sklep Komisije C(2010) 7593 z dne 27. oktobra 2010 o dodelitvi nepovratnih sredstev za predloge za leto 2010 v skladu z drugim Programom ukrepov skupnosti na področju zdravja (2008–2013), številka pogodbe 2010/2302.
Decision No 1350/2007/EC of the European Parliament and of the Council of 23 October 2007 establishing a second programme of Community action in the field of health (2008-2013) (OJ L 301, 20.11.2007, p. 3).
Sklep št. 1350/2007/ES Evropskega parlamenta in Sveta z dne 23. oktobra 2007 o uvedbi drugega programa ukrepov Skupnosti na področju zdravja (2008–2013) (UL L 301, 20.11.2007, str. 3).
Decision No 1639/2006/EC of the European Parliament and of the Council of 24 October 2006 establishing the Competitiveness and Innovation Framework Programme (2007 to 2013) (OJ L 310, 9.11.2006, p. 15).
Sklep št. 1639/2006/ES Evropskega parlamenta in Sveta z dne 24. oktobra 2006 o ustanovitvi Okvirnega programa za konkurenčnost in inovativnost (2007–2013) (UL L 310, 9.11.2006, str. 15).
OJ L 317, 31.12.2001, p. 1.
UL L 317, 31.12.2001, str. 1.
authorising the placing on the market of products containing, consisting of, or produced from genetically modified cotton 281-24-236x3006-210-23 (DAS-24236-5xDAS-21Ø23-5) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council
o odobritvi dajanja na trg proizvodov, ki vsebujejo gensko spremenjen bombaž 281-24-236x3006-210-23 (DAS-24236-5xDAS-21Ø23-5), so iz njega sestavljeni ali proizvedeni, v skladu z Uredbo (ES) št. 1829/2003 Evropskega parlamenta in Sveta
On 22 June 2005, Dow AgroSciences Europe submitted to the competent authority of the Netherlands an application, in accordance with Articles 5 and 17 of Regulation (EC) No 1829/2003, for the placing on the market of foods, food ingredients, and feed containing, consisting of, or produced from 281-24-236x3006-210-23 cotton (‘the application’).
Družba Dow AgroSciences Europe je 22. junija 2005 v skladu s členoma 5 in 17 Uredbe (ES) št. 1829/2003 pristojnemu organu Nizozemske predložila vlogo za dajanje na trg živil, živilskih sestavin in krme, ki vsebujejo bombaž 281-24-236x3006-210-23, so iz njega sestavljeni ali proizvedeni (v nadaljnjem besedilu: vloga).
The application also covers the placing on the market of products other than food and feed containing or consisting of 281-24-236x3006-210-23 cotton for the same uses as any other cotton with the exception of cultivation.
Vloga zajema tudi dajanje na trg drugih proizvodov, ki niso živila in krma ter vsebujejo bombaž 281-24-236x3006-210-23 ali so iz njega sestavljeni, za enako uporabo kot katera koli druga sorta bombaža, razen za gojenje.
On 15 June 2010, the European Food Safety Authority (‘EFSA’) gave a favourable opinion in accordance with Articles 6 and 18 of Regulation (EC) No 1829/2003.
(3) Evropska agencija za varnost hrane (v nadaljnjem besedilu: EFSA) je 15. junija 2010 dala ugodno mnenje v skladu s členoma 6 in 18 Uredbe (ES) št. 1829/2003.
It considered that cotton 281-24-236x3006-210-23 is as safe as its non-genetically modified counterpart with respect to potential effects on human and animal health or the environment.
Menila je, da je bombaž 281-24-236x3006-210-23 enako varen kot gensko nespremenjen bombaž glede možnih učinkov na zdravje ljudi in živali ali na okolje.
Therefore it concluded that it is unlikely that the placing on the market of the products containing, consisting of, or produced from 281-24-236x3006-210-23 cotton as described in the application (‘the products’) will have any adverse effects on human or animal health or the environment in the context of their intended uses [3].
Zato je ugotovila, da ni verjetno, da bi dajanje na trg proizvodov, ki vsebujejo bombaž 281-24-236x3006-210-23, so iz njega sestavljeni ali proizvedeni v skladu z opisom v vlogi (v nadaljnjem besedilu: proizvodi), lahko pri predvideni uporabi škodljivo vplivalo na zdravje ljudi ali živali ali na okolje [3].
However, due to the physical characteristics of cotton seeds and methods of its transportation, EFSA recommended that, within general surveillance, specific measures are introduced to actively monitor the occurrence of feral cotton plants in areas where seed spillage and plant establishment are likely to occur.
Vendar je EFSA zaradi fizikalnih značilnosti bombažnih semen in načinov prevoza priporočila, da se znotraj splošnega nadzora uvedejo posebni ukrepi za dejavno spremljanje divje rastočih rastlin bombaža na območjih, kjer sta verjetna razpršitev semena in širitev rastlin.
In order to better describe the monitoring requirements and to comply with the EFSA recommendation, the monitoring plan submitted by the applicant has been modified.
Za boljši opis zahtev za spremljanje in uskladitev s priporočilom EFSA je bil načrt spremljanja, ki ga je predložil vlagatelj, spremenjen.
On the basis of the EFSA opinion, no specific labelling requirements other than those provided for in Articles 13(1) and 25(2) of Regulation (EC) No 1829/2003, appear to be necessary for foods, food ingredients and feed containing, consisting of, or produced from 281-24-236x3006-210-23 cotton.
Na podlagi mnenja EFSA za živila, živilske sestavine in krmo, ki vsebujejo bombaž 281-24-236x3006-210-23, so iz njega sestavljeni ali proizvedeni, niso potrebne nobene druge zahteve za označevanje, razen zahtev iz člena 13(1) in člena 25(2) Uredbe (ES) št. 1829/2003.
Regulation (EC) No 1830/2003 of the European Parliament and of the Council of 22 September 2003 concerning the traceability and labelling of genetically modified organisms and the traceability of food and feed products produced from genetically modified organisms and amending Directive 2001/18/EC [5], lays down in Article 4(6) labelling requirements for products containing or consisting of GMOs.
Člen 4(6) Uredbe (ES) št. 1830/2003 Evropskega parlamenta in Sveta z dne 22. septembra 2003 o sledljivosti in označevanju gensko spremenjenih organizmov ter sledljivosti živil in krme, proizvedenih iz gensko spremenjenih organizmov, ter o spremembi Direktive 2001/18/ES [5] določa zahteve o označevanju proizvodov, ki vsebujejo GSO ali so iz njih sestavljeni.
Traceability requirements for products containing or consisting of GMOs are laid down in paragraphs 1 to 5 of Article 4 and for food and feed produced from GMOs are laid down in Article 5 of that Regulation.
Zahteve za sledljivost proizvodov, ki vsebujejo GSO ali so iz njih sestavljeni, so določene v odstavkih (1) do (5) člena 4, zahteve za živila in krmo, proizvedene iz GSO, pa so določene v členu 5 navedene uredbe.
The Standing Committee on the Food Chain and Animal Health has not delivered an opinion within the time limit laid down by its Chair and the Commission therefore submitted to the Council a proposal relating to these measures.
Stalni odbor za prehranjevalno verigo in zdravje živali ni dal mnenja v roku, ki ga je določil njegov predsednik, zato je Komisija Svetu predložila predlog v zvezi s temi ukrepi.
Since, at its meeting on 15 December 2011, the Council was unable to reach a decision by qualified majority either for or against the proposal and the Council indicated that its proceedings on this file were concluded, these measures are to be adopted by the Commission,
Ker Svet na srečanju 15. decembra 2011 ni mogel sprejeti odločitve s kvalificirano večino niti za predlog niti proti njemu in je sporočil, da so njegovi postopki v zvezi s tem predlogom končani, mora te ukrepe sprejeti Komisija –
Genetically modified cotton (Gossypium hirsutum) 281-24-236x3006-210-23, as specified in point (b) of the Annex to this Decision, is assigned the unique identifier DAS-24236-5xDAS-21Ø23-5, as provided for in Regulation (EC) No 65/2004.
Gensko spremenjenemu bombažu (Gossypium hirsutum) 281-24-236x3006-210-23, kakor je opredeljen v točki (b) Priloge k temu sklepu, se v skladu z Uredbo (ES) št. 65/2004 dodeli posebni identifikator DAS-24236-5xDAS-21Ø23-5.
foods and food ingredients containing, consisting of, or produced from DAS-24236-5xDAS-21Ø23-5 cotton;
živila in živilske sestavine, ki vsebujejo bombaž DAS-24236-5xDAS-21Ø23-5, so iz njega sestavljeni ali proizvedeni;
feed containing, consisting of, or produced from DAS-24236-5xDAS-21Ø23-5 cotton;
krma, ki vsebuje bombaž DAS-24236-5xDAS-21Ø23-5, je iz njega sestavljena ali proizvedena;
products other than food and feed containing or consisting of DAS-24236-5xDAS-21Ø23-5 cotton for the same uses as any other cotton with the exception of cultivation.
proizvodi, ki niso živila in krma ter vsebujejo bombaž DAS-24236-5xDAS-21Ø23-5, ali so iz njega sestavljeni, za enako uporabo kot katera koli druga sorta bombaža, razen za gojenje.
The words ‘not for cultivation’ shall appear on the label of and in documents accompanying products containing or consisting of DAS-24236-5xDAS-21Ø23-5 cotton referred to in Article 2(b) and (c).
Proizvodi iz člena 2(b) in (c), ki vsebujejo bombaž DAS-24236-5xDAS-21Ø23-5 ali so iz njega sestavljeni, in dokumenti, priloženi tem proizvodom, se označijo z besedami „ni za gojenje“.
The authorisation holder shall be Dow AgroSciences Europe, United Kingdom, representing Mycogen Seeds, United States.
Imetnik odobritve je družba Dow AgroSciences Europe, Združeno kraljestvo, kot predstavnik družbe Mycogen Seeds, Združene države.
This Decision is addressed to Dow AgroSciences Europe, European Development Centre, 3 Milton Park, Abingdon, Oxon OX14 4RN, United Kingdom
Ta sklep je naslovljen na družbo Dow AgroSciences Europe, European Development Centre, 3 Milton Park, Abingdon, Oxon OX14 4RN, Združeno kraljestvo
Applicant and Authorisation holder
Vlagatelj in imetnik odobritve
Address European Development Centre, 3 Milton Park, Abingdon, Oxon OX14 4RN, United Kingdom
Naslov European Development Centre, 3 Milton Park, Abingdon Oxon OX14 4RN, Združeno kraljestvo
Foods and food ingredients containing, consisting of, or produced from DAS-24236-5xDAS-21Ø23-5 cotton.
živila in živilske sestavine, ki vsebujejo bombaž DAS-24236-5xDAS-21Ø23-5, so iz njega sestavljeni ali proizvedeni;
Feed containing, consisting of, or produced from DAS-24236-5xDAS-21Ø23-5 cotton.
krma, ki vsebuje bombaž DAS-24236-5xDAS-21Ø23-5, je iz njega sestavljena ali proizvedena;
Products other than food and feed containing or consisting of DAS-24236-5xDAS-21Ø23-5 cotton for the same uses as any other cotton with the exception of cultivation.
proizvodi, ki niso živila in krma ter vsebujejo bombaž DAS-24236-5xDAS-21Ø23-5, ali so iz njega sestavljeni, za enako uporabo kot katera koli druga sorta bombaža, razen za gojenje.
The genetically modified DAS-24236-5xDAS-21Ø23-5 cotton (Gossypium hirsutum), as described in the application, expresses the Cry1Ac and Cry1F proteins which confer protection against certain lepidopteran pests and expresses PAT protein, used as a selectable marker, which confers tolerance to the glufosinate-ammonium herbicide.
Gensko spremenjen bombaž sorte DAS-24236-5xDAS-21Ø23-5 (Gossypium hirsutum), kakor je opisan v vlogi, izloča beljakovini Cry1Ac in Cry1F kot zaščito pred nekaterimi škodljivimi vrstami metuljev in beljakovino PAT, ki se uporablja kot izbirni označevalec in omogoča odpornost na herbicid glufosinat-amonij.
For the purposes of the specific labelling requirements laid down in Article 13(1) and Article 25(2) of Regulation (EC) No 1829/2003, and in Article 4(6) of Regulation (EC) No 1830/2003, the ‘name of the organism’ shall be ‘cotton’.
za namene zahtev za označevanje iz člena 13(1) in člena 25(2) Uredbe (ES) št. 1829/2003 ter člena 4(6) Uredbe (ES) št. 1830/2003 je „ime organizma“„bombaž“;
The words ‘not for cultivation’ shall appear on the label of and in documents accompanying products containing or consisting of DAS-24236-5xDAS-21Ø23-5 cotton referred to in Article 2(b) and (c) of this Decision.
proizvodi iz člena 2(b) in (c) tega sklepa, ki vsebujejo bombaž DAS-24236-5xDAS-21Ø23-5 ali so iz njega sestavljeni, in dokumenti, priloženi tem proizvodom, se označijo z besedami „ni za gojenje“.
Event specific real-time PCR based method for the quantification of DAS-24236-5xDAS-21Ø23-5 cotton.
kvantitativna, za pojav specifična metoda, ki temelji na verižni reakciji s polimerazo (PCR) za bombaž DAS-24236-5xDAS-21Ø23-5;
Validated on seeds by the Community reference laboratory established under Regulation (EC) No 1829/2003, published at https://irmm.jrc.ec.europa.eu/rmcatalogue
na podlagi semen jo potrdi referenčni laboratorij Skupnosti, ustanovljen z Uredbo (ES) št. 1829/2003, objavi pa se na spletni strani http://gmo-crl.jrc.ec.europa.eu/statusofdoss.htm;
Reference Material: ERM®-BF422 accessible via the Joint Research Centre (JRC) of the European Commission, Institute for Reference Materials and Measurements (IRMM) at http://gmo-crl.jrc.ec.europa.eu/statusofdoss.htm
referenčni material: ERM®-BF422 je na voljo pri Skupnem raziskovalnem središču (JRC) Evropske komisije, Inštituta za referenčne materiale in meritve (IRMM) na spletni strani https://irmm.jrc.ec.europa.eu/rmcatalogue
Biosafety Clearing-House, Record ID: see [to be completed when notified].
Urad za izmenjavo informacij o biološki varnosti, številka vpisa: glej [izpolniti po obvestilu]
authorising the placing on the market of products containing, consisting of, or produced from genetically modified maize MIR604xGA21 (SYN-IR6Ø4-5xMON-ØØØ21-9) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council
o odobritvi dajanja na trg proizvodov, ki vsebujejo gensko spremenjeno koruzo MIR604xGA21 (SYN-IR6Ø4-5xMON-ØØØ21-9), so iz nje sestavljeni ali proizvedeni, v skladu z Uredbo (ES) št. 1829/2003 Evropskega parlamenta in Sveta
On 31 October 2007, Syngenta Seeds SAS submitted to the competent authority of the United Kingdom an application, in accordance with Articles 5 and 17 of Regulation (EC) No 1829/2003, for the placing on the market of foods, food ingredients, and feed containing, consisting of, or produced from MIR604xGA21 maize (the application).
Družba Syngenta Seeds S.A.S je 31. oktobra 2007 v skladu s členoma 5 in 17 Uredbe (ES) št. 1829/2003 pristojnim organom Združenega kraljestva predložila vlogo za dajanje na trg živil, živilskih sestavin in krme, ki vsebujejo koruzo MIR604xGA21, so iz nje sestavljeni ali proizvedeni (v nadaljnjem besedilu: vloga).
The application also covers the placing on the market of products other than food and feed containing or consisting of MIR604xGA21 maize for the same uses as any other maize with the exception of cultivation.
Vloga zajema tudi dajanje na trg drugih proizvodov, ki niso živila in krma ter vsebujejo koruzo MIR604xGA21 ali so iz nje sestavljeni, za enako uporabo kot katera koli druga koruza, razen za gojenje.
Therefore, in accordance with Articles 5(5) and 17(5) of Regulation (EC) No 1829/2003, it includes the data and information required by Annexes III and IV to Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the environment of genetically modified organisms and repealing Council Directive 90/220/EEC [2] and information and conclusions about the risk assessment carried out in accordance with the principles set out in Annex II to Directive 2001/18/EC.
Zato vloga v skladu s členom 5(5) in členom 17(5) Uredbe (ES) št. 1829/2003 vključuje podatke in informacije v skladu s prilogama III in IV k Direktivi 2001/18/ES Evropskega parlamenta in Sveta z dne 12. marca 2001 o namernem sproščanju gensko spremenjenih organizmov v okolje in razveljavitvi Direktive Sveta 90/220/EGS [2] ter informacije in sklepe o oceni tveganja, opravljeni po načelih iz Priloge II k Direktivi 2001/18/ES.
On 18 May 2010, the European Food Safety Authority (EFSA) gave a favourable opinion in accordance with Articles 6 and 18 of Regulation (EC) No 1829/2003.
(3) Evropska agencija za varnost hrane (v nadaljnjem besedilu: EFSA) je 18. maja 2010 dala ugodno mnenje v skladu s členoma 6 in 18 Uredbe (ES) št. 1829/2003.
It considered that maize MIR604xGA21 is as safe as its non-genetically modified counterpart with respect to potential effects on human and animal health or the environment.
Menila je, da je koruza MIR604xGA21 enako varna kot gensko nespremenjena koruza glede možnih učinkov na zdravje človeka in živali ali okolje.
Therefore, it concluded that it is unlikely that the placing on the market of the products containing, consisting of, or produced from MIR604xGA21 maize as described in the application (the products) will have any adverse effects on human or animal health or the environment in the context of their intended uses [3].
Zato je ugotovila, da ni verjetno, da bo dajanje na trg proizvodov, ki vsebujejo koruzo MIR604xGA21, so iz nje sestavljeni ali proizvedeni, kakor je opisano v vlogi (v nadaljnjem besedilu: proizvodi), ob predvideni uporabi imelo škodljive učinke na zdravje ljudi, živali ali okolje [3].
On the basis of the EFSA opinion, no specific labelling requirements other than those provided for in Articles 13(1) and 25(2) of Regulation (EC) No 1829/2003, appear to be necessary for foods, food ingredients and feed containing, consisting of, or produced from MIR604xGA21 maize.
V skladu z mnenjem EFSA za živila, živilske sestavine in krmo, ki vsebujejo koruzo MIR604xGA21, so iz nje sestavljeni ali proizvedeni, niso potrebne nobene posebne zahteve za označevanje, razen tistih iz členov 13(1) in 25(2) Uredbe (ES) št. 1829/2003.